Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Journal of Crohn'S & Colitis
|
August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Journal of Crohn'S & Colitis
|
April 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
María Chaparro, Ana Garre, Marisa Iborra, et al.
Inflammatory Bowel Diseases
|
February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Journal of Clinical Medicine
|
August 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Journal of Crohn'S & Colitis
|
August 1, 2022
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Journal of Crohn'S & Colitis
|
April 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
María Chaparro, Ana Garre, Marisa Iborra, et al.
Inflammatory Bowel Diseases
|
February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Journal of Clinical Medicine
|
August 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Page
of 14